Buscar
Mostrando ítems 1-10 de 27
Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group
(2022)
CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. However, to date, there ...
Immunization and SARS-CoV-2 antibody seroprevalence in a country with high vaccination coverage: Lessons from Chile
(2022)
Objective: Chile is among the most successful nations worldwide in COVID-19 vaccine rollout. By December 31st, 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses using DIFFERENT TYPES OF ...
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
(Elsevier, 2022)
Background By July 14, 2021, 81.3 % of adults (aged >= 18 years) in Chile had received a first SARS-CoV-2 vaccine and 72.3% had received a second SARS-CoV-2 vaccine, with the majority of people given Sinovac's inactivated ...
Humoral immune response of BNT162b2 and CoronaVac vaccinations in hemodialysis patients: a multicenter prospective cohort
(MDPI, 2022)
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2. End-stage renal disease (ESRD) patients ...
Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile
(NATURE PORTFOLIO, 2022)
The outbreak of the B.1.1.529 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Omicron) has caused an unprecedented number of Coronavirus Disease 2019 (COVID-19) cases, including pediatric hospital ...
Effectiveness of CoronaVac in children 3–5 years of age during the SARS-CoV-2 Omicron outbreak in Chile
(2022)
The outbreak of the B.1.1.529 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Omicron) has caused an unprecedented number of Coronavirus Disease 2019 (COVID-19) cases, including pediatric hospital ...
Low performance of sinovac vaccine particularly with belatacept therapy in a study with different types of COVID-19 vaccines in transplanted patients
(Elsevier, 2023)
The huge impact of SARS-CoV-2 infections on organ transplant recipients makes it necessary to
optimize vaccine efficacy in this population. To effectively implement multiple strategies, it is
crucial to understand the ...
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
(Elsevier Ltd, 2022)
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseBackground: Several countries have authorised or begun using a booster vaccine dose against COVID-19. Policy makers ...